동결건조 서비스 시장 : 업계 동향과 세계 예측 - 동결건조되는 생물제제 유형별, 일차 포장 시스템 유형별, 주요 지역별

Lyophilization Services Market : Industry Trends and Global Forecasts - Distribution by Type of Biologic Lyophilized, Type of Primary Packaging System and Key Geographies

US $ 4,799 ￦ 6,928,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,999 ￦ 10,105,000

PDF (One-Location Site License)

PDF 보고서를 동일 사업장의 특정 사업 부문에 속한 모든 분들이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,599 ￦ 15,302,000

PDF (Department License)

PDF 보고서를 부서 단위로 12명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 17,999 ￦ 25,986,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

동결건조 서비스 시장 : 개요

세계의 동결건조 서비스 시장 규모는 2035년까지의 예측 기간 중 6.3%의 CAGR로 확대하며, 현재 26억 달러에서 2035년까지 49억 달러로 성장할 것으로 예측됩니다.

시장 세분화에서는 시장 규모 및 기회 분석을 다음과 같은 매개 변수로 구분합니다.

동결 건조되는 생물제제 유형

• 항체
• 세포-유전자 치료제
• 백신
• 기타 생물제제

1차 포장 시스템 유형

• 바이알
• 주사기
• 카트리지
• 앰플
• 기타

주요 지역

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 북아프리카

동결건조 서비스 시장 : 성장과 동향

동결건조는 의약품의 안정화 기술로서 물질의 화학적 성질을 유지한 채 동결건조를 통해 물과 같은 여분의 용매를 제거합니다. 특히 동결건조에는 실험실용 동결건조기, 비멸균 동결건조기, 멸균 동결건조기 등 특수한 장비가 사용됩니다. 수년 동안 동결 건조가 상업적으로 실행 가능한 더 긴 저장 기간을 달성하고 안정적이고 건조한 생물제제 제제를 가능하게 하는 바람직한 접근법으로 부상한 것은 주목할 만합니다. 그러나 바이오시밀러 및 신규 바이오의약품의 파이프라인이 빠르게 성장하고 있고, 바이오의약품 동결건조와 관련된 여러 가지 과제가 존재하므로 이해관계자들은 이 분야에서 다학제적 전문성을 제공하는 서비스 프로바이더에 대한 의존도가 높아지고 있습니다.

또한 일부 시장 리더들은 작업 효율을 개선하고 건조 공정 중 공정 제어를 달성하기 위해 동결 건조 기술의 발전과 혁신을 위한 연구를 가속화하고 있습니다. 그 결과 전체 공정의 생산성과 효율성이 향상되었습니다. 예를 들어 연속 동결 건조 시스템 및 자동 동결 건조 시스템과 같은 최신 기술은 업계 리더들이 이러한 기술을 채택하여 고객의 맞춤형 동결 건조 서비스 요구 사항을 충족하도록 촉구하고 있습니다.

동결건조 서비스 시장 : 주요 인사이트

이 보고서는 동결건조 서비스 시장의 현황을 조사하고 잠재적인 성장 기회를 파악합니다. 주요 조사 결과는 다음과 같습니다.

• 현재 105개 이상의 서비스 프로바이더가 단백질, 항체, 핵산, 세포/유전자 치료제를 포함한 다양한 바이오 치료제의 동결건조 서비스를 제공하는 데 필요한 전문성을 보유하고 있다고 주장하고 있습니다.
• 현재 시장 상황은 매우 파편화되어 있으며, 신규 진출기업과 주요 지역에 기반을 둔 기존 기업이 모두 존재하고 있습니다.
• 이해관계자들은 각자의 전문성을 활용하여 다양한 규모의 동결건조 서비스를 제공합니다. 또한 바이알은 생물제제를 보관하기 위한 1차 포장 시스템으로서 선호되는 선택으로 부상하고 있습니다.

• 진화하는 규제 환경을 잘 극복하기 위해 서비스 제공 업체는 고객의 맞춤형 요구를 충족시키기 위해 포트폴리오를 확장하고 있습니다.
• 이 분야에 대한 관심 증가는 제휴 활동 증가에서도 알 수 있으며, 실제로 지난 2년간 생물제제 동결건조와 관련된 제휴가 가장 많았습니다.
• 증가하는 수요에 대응하기 위해 많은 기업이 새로운 시설의 설립, 기존 시설의 확장 등 서비스 포트폴리오를 강화하기 위한 확장 방안을 마련하고 있습니다.
• 시장은 2035년까지 안정적인 속도로 성장할 것으로 예상되며, 예측된 기회는 다양한 유형의 생물제제 동결건조, 1차 포장 시스템, 지역적 지역별로 잘 분배될 것으로 예측됩니다.

동결건조 서비스 시장 : 주요 부문

동결건조되는 생물제제 유형별로 시장은 항체, 세포 및 유전자 치료제, 백신, 기타 생물제제로 구분됩니다. 현재 항체 분야가 전 세계 동결건조 서비스 시장에서 가장 큰 비중을 차지하고 있습니다. 이러한 추세는 무수한 질병 치료를 위한 표적 특이적 약물에 대한 수요 증가로 인해 향후 수년간 지속될 것으로 예측됩니다.

1차 포장 시스템 유형별로 시장은 바이알, 주사기, 카트리지, 앰플, 기타로 구분됩니다. 현재 바이알 부문이 세계 동결건조 서비스 시장에서 가장 큰 점유율을 차지하고 있습니다. 그러나 자동 약물전달 주사 및 프리필드 시린지에 대한 수요가 증가함에 따라 주사기 시장은 예측 기간 중 더 높은 CAGR로 성장할 것으로 예측됩니다.

주요 지역별로 시장은 북미, 유럽, 아시아태평양, 중남미, 중동 및 북아프리카, 라틴아메리카로 구분됩니다. 현재 북미는 전 세계 동결 건조 서비스 시장에서 가장 큰 매출 점유율을 차지하고 있습니다. 또한 아시아태평양 시장은 향후 더 높은 CAGR로 성장할 가능성이 높습니다.

동결건조 서비스 시장의 참여 기업 예

• Baxter BioPharma Solutions
• CordenPharma
• Coriolis Pharma
• Curia
• Emergent BioSolutions
• LSNE Contract Manufacturing
• Lyophilization Technology
• Northway Biotech
• ProJect Pharmaceutics
• Vetter Pharma

목차

제1장 서문

제2장 개요

제3장 서론

• 챕터 개요
• 동결건조의 개요
• 생물제제의 동결건조
• 동결건조기와 주요 컴포넌트
• 생물제제의 동결건조에 사용되는 일차 포장 시스템
• 동결건조 사이클의 개발과 최적화
• 결론

제4장 시장 구도

• 챕터 개요
• 생물제제용 동결건조 서비스 프로바이더 : 시장 구도

제5장 벤치마크 분석

• 챕터 개요
• 조사 방법
• 벤치마크 분석 : 피어 그룹

제6장 기업 개요 : 북미의 생물제제 동결건조 서비스 프로바이더

• 챕터 개요
• Baxter BioPharma Solutions
• Curia
• Emergent BioSolutions
• LSNE Contract Manufacturing
• Lyophilization Technology

제7장 기업 개요 : 유럽의 생물제제 동결건조 서비스 프로바이더

• 챕터 개요
• CordenPharma
• Coriolis Pharma
• Northway Biotech
• ProJect Pharmaceutics
• Vetter Pharma

제8장 기업 개요 : 아시아태평양의 생물제제 동결건조 서비스 프로바이더

• 챕터 개요
• BioZed Engineering
• CinnaGen
• MabPlex
• Samsung Biologics
• WuXi Biologics

제9장 파트너십과 협업

• 챕터 개요
• 파트너십 모델
• 생물제제 동결건조 서비스 : 파트너십과 협업 리스트

제10장 최근 확장

• 챕터 개요
• 생물제제 동결건조 서비스 시장 : 최근 확대 리스트

제11장 조사 분석

• 챕터 개요
• 생물제제 동결건조 서비스 시장 : 참가 기업 리스트

제12장 사례 연구 I : 동결건조 사이클의 개발과 최적화

• 챕터 개요
• 동결건조 사이클 개발
• 동결건조 사이클 최적화
• 동결건조 사이클 개발과 최적화 : 서비스 프로바이더 리스트

제13장 사례 연구 II : 동결건조 대체 어프로치

• 챕터 개요
• 동결건조의 대체 어프로치

제14장 시장 예측과 기회 분석

• 챕터 개요
• 예측 조사 방법과 주요 전제조건
• 세계의 생물제제용 동결건조 서비스 시장(-2035년)
• 생물제제 동결건조 서비스 시장 : 동결건조되는 생물제제 유형별
• 생물제제 동결건조 서비스 시장 : 일차 포장 시스템 유형별
• 생물제제 동결건조 서비스 시장 : 지역별

제15장 결론

제16장 이그제큐티브 인사이트

제17장 부록 1 : 표형식 데이터

제18장 부록 2 : 기업·단체 리스트

KSA

영문 목차

영문목차

LYOPHILIZATION SERVICES MARKET: OVERVIEW

As per Roots Analysis, the global lyophilization services market is estimated to grow from USD 2.6 billion in the current year to USD 4.9 billion by 2035, at a CAGR of 6.3% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Biologic Lyophilized

• Antibodies
• Cells and Gene Therapies
• Vaccines
• Other Biologics

Type of Primary Packaging System

• Vials
• Syringes
• Cartridges
• Ampoules
• Others

Key Geographies

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and North Africa

LYOPHILIZATION SERVICES MARKET: GROWTH AND TRENDS

Lyophilization is a drug stabilization technique that involves removing excess solvents, such as water, through freeze-drying while preserving the chemical properties of the substance. Notably, lyophilization utilizes specialized equipment, including laboratory freeze dryers, non-sterile freeze dryers, and sterilizable lyophilizers. It is worth highlighting that over the years, lyophilization has emerged as the preferred approach to achieve longer and commercially viable shelf lives, enabling stable and dry biopharmaceutical formulations. However, characterized by a rapidly growing pipeline of biosimilars and novel biologics, and the existing challenges associated with lyophilization of biotherapeutics, stakeholders are increasingly relying on service providers that offer multidisciplinary expertise in this domain.

In addition, several market leaders are accelerating their research for lyophilization technology advancements and innovations to improve working efficiency and achieve process control during the drying process. This has resulted in improved productivity and efficiency of the overall process. For instance, latest technologies, such as continuous freeze-drying systems and automated lyophilization systems, are encouraging industrial leaders to adopt these technologies and meet the customized lyophilization services requirements of clients.

LYOPHILIZATION SERVICES MARKET: KEY INSIGHTS

The report delves into the current state of the lyophilization services market and identifies potential growth opportunities within industry. Some key findings from the report include:

• Presently, over 105 service providers claim to have the required expertise to offer lyophilization services for a variety of biotherapeutics, including proteins, antibodies, nucleic acids and cell / gene therapies.
• The current market landscape is highly fragmented, featuring the presence of both new entrants and established players based in key geographical regions.
• Leveraging their expertise, stakeholders are offering lyophilization services at different scales of operation; further, vials emerged as the preferred choice of primary packaging system for storing biologics.

• In order to successfully navigate the evolving regulatory landscape, service providers are expanding their portfolios to cater to customized requests of their clients.
• The growing interest in this domain is evident from the rise in partnership activity; in fact, the maximum number of collaborations related to lyophilization of biopharmaceuticals were signed in the past two years.
• To keep pace with the growing demand, many companies have undertaken expansion initiatives, such as establishing new facilities or expanding their existing capabilities, to strengthen their service portfolio.
• The market is expected to grow at a steady rate till 2035; the projected opportunity is anticipated to be well distributed across various types of biologic lyophilized, primary packaging systems and geographical regions.

LYOPHILIZATION SERVICES MARKET: KEY SEGMENTS

Antibodies Segment holds the Largest Share of the Lyophilization Services Market

Based on the type of biologics lyophilized, the market is segmented into antibodies, cell and gene therapies, vaccines, and other biologics. At present, the antibodies segment holds the maximum share of the global lyophilization services market. This trend is likely to remain the same in the coming years owing to the increasing demand for target-specific drugs for the treatment of a myriad of diseases.

By Type of Primary Packaging System, Syringes is the Fastest Growing Segment of the Global Lyophilization Services Market

Based on the type of primary packaging system, the market is segmented into vials, syringes, cartridges, ampoules, and others. At present, the vials segment holds the maximum share of the global lyophilization services market. However, the market for syringes segment is expected to grow at a higher CAGR during the forecast period owing to the growing demand for automated drug delivery injections and prefilled syringes.

North America Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa and Latin America. Currently, North America dominates the global lyophilization services market and accounts for the largest revenue share. Further, the market in Asia-Pacific is likely to grow at a higher CAGR in the coming future.

Example Players in the Lyophilization Services Market

• Baxter BioPharma Solutions
• CordenPharma
• Coriolis Pharma
• Curia
• Emergent BioSolutions
• LSNE Contract Manufacturing
• Lyophilization Technology
• Northway Biotech
• ProJect Pharmaceutics
• Vetter Pharma

LYOPHILIZATION SERVICES MARKET: RESEARCH COVERAGE

• Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global lyophilization services market, focusing on key market segments, including [A] type of biologic lyophilized, [B] type of primary packaging system and [C] key geographies.
• Market Landscape: A comprehensive evaluation of the companies offering lyophilization services, based on several relevant parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, [D] the scale of operation, [E] regulatory certification / accreditation, [F] type of biologic lyophilized, [G] the process of lyophilization, [H] type of primary packaging system and [I] additional services offered by the firms.
• Benchmark Analysis: A comprehensive benchmark analysis of various service providers segregated into three peer groups based on the location of their headquarters. Additionally, the companies were further distributed across key geographies, based on their employee count, into three categories, namely [A] small, [B] mid-sized and [C] large / very large, highlighting the top players in the lyophilization services market, based on their respective capabilities.
• Company Profiles: In-depth profiles of key players that are currently engaged in offering lyophilization services for biopharmaceuticals, focusing on [A] overview of the company, [B] lyophilization service offerings for biopharmaceuticals, [C] dedicated facilities and [D] recent developments and an informed future outlook.
• Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in this domain, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] most active players (in terms of the number of partnerships signed) and [D] geographical distribution.
• Recent Expansions: In-depth analysis of the various expansion initiatives undertaken by lyophilization service providers for biopharmaceuticals, based on several parameters, such as [A] year of expansion, [B] type of expansion, [C] company size, [D] location of headquarters, [E] location of expanded facility, [F] most active players (in terms of number of recent expansions) and [G] geographical distribution.
• Survey Analysis: An insightful analysis presenting additional insights on lyophilization services offered for biopharmaceuticals, based on several parameters, such as [A] type of biologic lyophilized, [B] type of primary packaging system, [C] scale of operation, [D] availability of lyophilization cycle development / optimization capabilities and [E] location of a dedicated manufacturing facility for lyophilization.
• Case Study 1: A detailed discussion on lyophilization cycle development and optimization services, highlighting the important parameters and techniques required for these processes.
• Case Study 2: A comprehensive discussion on the alternative approaches to the lyophilization process, such as [A] spray drying, [B] spray freeze dryer, [C] atmospheric spray freeze dryer, and [D] vacuum foam drying.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How many companies are currently engaged in this market?
• Which are the leading companies in this market?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 15% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

• 1.1. Scope of the Report
• 1.2. Research Methodology
  • 1.2.1. Research Assumptions
  • 1.2.2. Project Methodology
  • 1.2.3. Forecast Methodology
  • 1.2.4. Robust Quality Control
  • 1.2.5. Key Considerations
    • 1.2.5.1. Demographics
    • 1.2.5.2. Economic Factors
    • 1.2.5.3. Government Regulations
    • 1.2.5.4. Supply Chain
    • 1.2.5.5. COVID Impact / Related Factors
    • 1.2.5.6. Market Access
    • 1.2.5.7. Healthcare Policies
    • 1.2.5.8. Industry Consolidation
• 1.3 Key Questions Answered
• 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

• 3.1. Chapter Overview
• 3.2. Overview of Lyophilization
  • 3.2.1. Historical Evolution
  • 3.2.2. Underlying Principles
  • 3.2.3. Advantages and Disadvantages
• 3.3. Lyophilization of Biopharmaceuticals
  • 3.3.1. Need for Lyophilization of Biopharmaceuticals
  • 3.3.2. Lyophilization Process
    • 3.3.2.1. Formulation and Filling
    • 3.3.2.2. Freezing
    • 3.3.2.3. Primary Drying
    • 3.3.2.4. Secondary Drying
• 3.4. Lyophilizer and its Key Components
• 3.5. Primary Packaging Systems Used for Lyophilization of Biopharmaceuticals
• 3.6. Lyophilization Cycle Development and Optimization
• 3.7. Concluding Remarks

4. MARKET LANDSCAPE

• 4.1. Chapter Overview
• 4.2. Lyophilization Service Providers for Biopharmaceuticals: Overall Market Landscape
  • 4.2.1. Analysis by Year of Establishment
  • 4.2.2. Analysis by Company Size
  • 4.2.3. Analysis by Location of Headquarters
  • 4.2.4. Analysis by Scale of Operation
  • 4.2.5. Analysis by Regulatory Certification / Accreditation
  • 4.2.6. Analysis by Type of Biologic Lyophilized
  • 4.2.7. Analysis by Process of Lyophilization
  • 4.2.8. Analysis by Type of Primary Packaging System
  • 4.2.9. Analysis by Additional Services Offered

5. BENCHMARK ANALYSIS

• 5.1. Chapter Overview
• 5.2. Methodology
• 5.3. Benchmark Analysis: Peer Groups
  • 5.3.1. Benchmark Analysis: North America (Peer Group I)
  • 5.3.2. Benchmark Analysis: North America (Peer Group II)
  • 5.3.3. Benchmark Analysis: North America (Peer Group III)
  • 5.3.4. Benchmark Analysis: Europe (Peer Group IV)
  • 5.3.5. Benchmark Analysis: Europe (Peer Group V)
  • 5.3.6. Benchmark Analysis: Europe (Peer Group VI)
  • 5.3.7. Benchmark Analysis: Asia Pacific and Rest of the World (Peer Group VII)
  • 5.3.8. Benchmark Analysis: Asia Pacific and Rest of the World (Peer Group VIII)

6. COMPANY PROFILES: LYOPHILIZATION SERVICE PROVIDERS FOR BIOPHARMACEUTICALS IN NORTH AMERICA

• 6.1. Chapter Overview
• 6.2. Baxter BioPharma Solutions
  • 6.2.1. Company Overview
  • 6.2.2. Lyophilization Service Offerings for Biopharmaceuticals
  • 6.2.3. Dedicated Biopharmaceutical Lyophilization Facilities
  • 6.2.4. Recent Developments and Future Outlook
• 6.3. Curia
  • 6.3.1. Company Overview
  • 6.3.2. Lyophilization Service Offerings for Biopharmaceuticals
  • 6.3.3. Dedicated Biopharmaceutical Lyophilization Facilities
  • 6.3.4. Recent Developments and Future Outlook
• 6.4. Emergent BioSolutions
  • 6.4.1. Company Overview
  • 6.4.2. Lyophilization Service Offerings for Biopharmaceuticals
  • 6.4.3. Dedicated Biopharmaceutical Lyophilization Facilities
  • 6.4.4. Recent Developments and Future Outlook
• 6.5. LSNE Contract Manufacturing
  • 6.5.1. Company Overview
  • 6.5.2. Lyophilization Service Offerings for Biopharmaceuticals
  • 6.5.3. Dedicated Biopharmaceutical Lyophilization Facilities
  • 6.5.4. Recent Developments and Future Outlook
• 6.6. Lyophilization Technology
  • 6.6.1. Company Overview
  • 6.6.2. Lyophilization Service Offerings for Biopharmaceuticals
  • 6.6.3. Dedicated Biopharmaceutical Lyophilization Facilities
  • 6.6.4. Recent Developments and Future Outlook

7. COMPANY PROFILES: LYOPHILIZATION SERVICE PROVIDERS FOR BIOPHARMACEUTICALS IN EUROPE

• 7.1. Chapter Overview
• 7.2. CordenPharma
  • 7.2.1. Company Overview
  • 7.2.2. Lyophilization Service Offerings for Biopharmaceuticals
  • 7.2.3. Dedicated Biopharmaceutical Lyophilization Facilities
  • 7.2.4. Recent Developments and Future Outlook
• 7.3. Coriolis Pharma
  • 7.3.1. Company Overview
  • 7.3.2. Lyophilization Service Offerings for Biopharmaceuticals
  • 7.3.3. Dedicated Biopharmaceutical Lyophilization Facilities
  • 7.3.4. Recent Developments and Future Outlook
• 7.4. Northway Biotech
  • 7.4.1. Company Overview
  • 7.4.2. Lyophilization Service Offerings for Biopharmaceuticals
  • 7.4.3. Dedicated Biopharmaceutical Lyophilization Facilities
  • 7.4.4. Recent Developments and Future Outlook
• 7.5. ProJect Pharmaceutics
  • 7.5.1. Company Overview
  • 7.5.2. Lyophilization Service Offerings for Biopharmaceuticals
  • 7.5.3. Dedicated Biopharmaceutical Lyophilization Facilities
  • 7.5.4. Recent Developments and Future Outlook
• 7.6. Vetter Pharma
  • 7.6.1. Company Overview
  • 7.6.2. Lyophilization Service Offerings for Biopharmaceuticals
  • 7.6.3. Dedicated Biopharmaceutical Lyophilization Facilities
  • 7.6.4. Recent Developments and Future Outlook

8. COMPANY PROFILES: LYOPHILIZATION SERVICE PROVIDERS FOR BIOPHARMACEUTICALS IN ASIA PACIFIC

• 8.1. Chapter Overview
• 8.2. BioZed Engineering
  • 8.2.1. Company Overview
  • 8.2.2. Lyophilization Service Offerings for Biopharmaceuticals
  • 8.2.3. Dedicated Biopharmaceutical Lyophilization Facilities
  • 8.2.4. Recent Developments and Future Outlook
• 8.3. CinnaGen
  • 8.3.1. Company Overview
  • 8.3.2. Lyophilization Service Offerings for Biopharmaceuticals
  • 8.3.3. Dedicated Biopharmaceutical Lyophilization Facilities
  • 8.3.4. Recent Developments and Future Outlook
• 8.4. MabPlex
  • 8.4.1. Company Overview
  • 8.4.2. Lyophilization Service Offerings for Biopharmaceuticals
  • 8.4.3. Dedicated Biopharmaceutical Lyophilization Facilities
  • 8.4.4. Recent Developments and Future Outlook
• 8.5. Samsung Biologics
  • 8.5.1. Company Overview
  • 8.5.2. Lyophilization Service Offerings for Biopharmaceuticals
  • 8.5.3. Dedicated Biopharmaceutical Lyophilization Facilities
  • 8.5.4. Recent Developments and Future Outlook
• 8.6. WuXi Biologics
  • 8.6.1. Company Overview
  • 8.6.2. Lyophilization Service Offerings for Biopharmaceuticals
  • 8.6.3. Dedicated Biopharmaceutical Lyophilization Facilities
  • 8.6.4. Recent Developments and Future Outlook

9. PARTNERSHIPS AND COLLABORATIONS

• 9.1. Chapter Overview
• 9.2. Partnership Models
• 9.3. Lyophilization Services for Biopharmaceuticals: List of Partnerships and Collaborations
  • 9.3.1. Analysis by Year of Partnership
  • 9.3.2. Analysis by Type of Partnership
  • 9.3.3. Analysis by Year and Type of Partnership
  • 9.3.4. Most Active Players: Analysis by Number of Partnerships
  • 9.3.5. Analysis by Geography
    • 9.3.5.1. Intercontinental and Intracontinental Deals
    • 9.3.5.2. International and Local Deals

10. RECENT EXPANSIONS

• 10.1. Chapter Overview
• 10.2. Lyophilization Services Market for Biopharmaceuticals: List of Recent Expansions
  • 10.2.1. Analysis by Year of Expansion
  • 10.2.2. Analysis by Type of Expansion
  • 10.2.3. Analysis by Year and Type of Expansion
  • 10.2.4. Analysis by Company Size and Location of Headquarters
  • 10.2.5. Analysis by Location of Expanded Facility
  • 10.2.6. Active Players: Analysis by Number of Recent Expansions
  • 10.2.7. Analysis by Geography

11. SURVEY ANALYSIS

• 11.1. Chapter Overview
• 11.2. Lyophilization Services Market for Biopharmaceuticals: List of Participating Companies
  • 11.2.1. Analysis by Seniority Level of Respondents
  • 11.2.2. Analysis by Type of Biologic Lyophilized
  • 11.2.3. Analysis by Type of Primary Packaging System
  • 11.2.4. Analysis by Scale of Operation
  • 11.2.5. Analysis by Additional Services Offered
  • 11.2.6. Analysis by Location of Lyophilization Facility
  • 11.2.7. Analysis by Share of Lyophilization Operations Outsourced
  • 11.2.8. Analysis by Likely Market Size
  • 11.2.9. Analysis of Likely Market Share by Type of Biologic Lyophilized
  • 11.2.10. Analysis of Likely Market Share by Geography

12. CASE STUDY I: LYOPHILIZATION CYCLE DEVELOPMENT AND OPTIMIZATION

• 12.1. Chapter Overview
• 12.2. Lyophilization Cycle Development
• 12.3. Lyophilization Cycle Optimization
• 12.4. Lyophilization Cycle Development and Optimization: List of Service Providers
  • 12.4.1. Analysis by Company Size
  • 12.4.2. Analysis by Location of Headquarters
  • 12.4.3. Analysis by Type of Service Offered
  • 12.4.4. Lyophilization Cycle Development and Optimization Service Providers: Company Snapshots

13. CASE STUDY II: ALTERNATIVE APPROACHES TO LYOPHILIZATION

• 13.1. Chapter Overview
• 13.2. Alternative Approaches to Lyophilization
  • 13.2.1. Spray Drying
    • 13.2.1.1. Spray Drying Process
    • 13.2.1.2. Applications of Spray Drying
    • 13.2.1.3. Spray Drying of Biopharmaceuticals
    • 13.2.1.4. Spray Drying Service Providers for Biopharmaceuticals
    • 13.2.1.5. Comparison of Lyophilization and Spray Drying
  • 13.2.2. Spray Freeze Drying
  • 13.2.3. Atmospheric Spray Freeze Drying
  • 13.2.4. Vacuum Foam Drying

14. MARKET FORECAST AND OPPORTUNITY ANALYSIS

• 14.1. Chapter Overview
• 14.2. Forecast Methodology and Key Assumptions
• 14.3. Global Lyophilization Services Market for Biopharmaceuticals, Till 2035
• 14.4. Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Biologic Lyophilized
  • 14.4.1. Lyophilization Services Market for Antibodies, Till 2035
  • 14.4.2. Lyophilization Services Market for Cell and Gene Therapies, Till 2035
  • 14.4.3. Lyophilization Services Market for Vaccines, Till 2035
  • 14.4.4. Lyophilization Services Market for Other Biologics, Till 2035
• 14.5. Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Primary Packaging System
  • 14.5.1. Lyophilization Services Market for Biopharmaceuticals for Vials, Till 2035
  • 14.5.2. Lyophilization Services Market for Biopharmaceuticals for Syringes, Till 2035
  • 14.5.3. Lyophilization Services Market for Biopharmaceuticals for Cartridges, Till 2035
  • 14.5.4. Lyophilization Services Market for Biopharmaceuticals for Ampoules, Till 2035
  • 14.5.5. Lyophilization Services Market for Biopharmaceuticals for Other Primary Packaging Systems, Till 2035
• 14.6. Lyophilization Services Market for Biopharmaceuticals: Distribution by Geography
  • 14.6.1. Lyophilization Services Market for Biopharmaceuticals in North America, Till 2035
  • 14.6.2. Lyophilization Services Market for Biopharmaceuticals in Europe, Till 2035
  • 14.6.3. Lyophilization Services Market for Biopharmaceuticals in Asia Pacific, Till 2035
  • 14.6.4. Lyophilization Services Market for Biopharmaceuticals in Middle East and North Africa, Till 2035
  • 14.6.5. Lyophilization Services Market for Biopharmaceuticals in Latin America, Till 2035
  • 14.6.6. Lyophilization Services Market for Biopharmaceuticals in Rest of the World, Till 2035

15. CONCLUDING REMARKS

16. EXECUTIVE INSIGHTS

• 16.1. Chapter Overview
• 16.2. Company A
  • 16.2.1. Company Snapshot
  • 16.2.2. Interview Transcript
• 16.3. Company B
  • 16.3.1. Company Snapshot
  • 16.3.2. Interview Transcript
• 16.4. Company C
  • 16.4.1. Company Snapshot
  • 16.4.2. Interview Transcript
• 16.5. Company D
  • 16.5.1. Company Snapshot
  • 16.5.2. Interview Transcript
• 16.6. Company E
  • 16.6.1. Company Snapshot
  • 16.6.2. Interview Transcript
• 16.7. Company F
  • 16.7.1. Company Snapshot
  • 16.7.2. Interview Transcript
• 16.8. Company G
  • 16.8.1. Company Snapshot
  • 16.8.2. Interview Transcript
• 16.9. Company H
  • 16.9.1. Company Snapshot
  • 16.9.2. Interview Transcript
• 16.10. Company I
  • 16.10.1. Company Snapshot
  • 16.10.2. Interview Transcript
• 16.11. Company J
  • 16.11.1. Company Snapshot
  • 16.11.2. Interview Transcript

17. APPENDIX 1: TABULATED DATA

18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

관련자료